Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 20.797.03-63.65475.4870.50

What is the latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS is 20.79 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202520.79
Mar20247.03
Mar2023-63.65
Mar2022475.48
Mar202170.50

How is Core EBITDA Growth of KWALITY PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 20.79
195.73
Mar2024 7.03
Positive
Mar2023 -63.65
Negative
Mar2022 475.48
574.44
Mar2021 70.5 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹992.4 Cr 6.5% 8.3% -0.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,536.0 Cr 0.1% 4.3% -1.1% Stock Analytics
DIVIS LABORATORIES ₹170,753.0 Cr -0.6% -1.3% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,650.0 Cr 0.5% -0.6% 13.7% Stock Analytics
CIPLA ₹122,143.0 Cr -0.6% -0.5% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,244.0 Cr -0.2% 3.6% -0.3% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

6.5%

8.3%

-0.2%

SENSEX

-0.5%

1.1%

3.8%


You may also like the below Video Courses